Search for: "In Re: Pfizer Securities Litigation"
Results 1 - 20
of 105
Sorted by Relevance
|
Sort by Date
1 Aug 2011, 7:18 am
When Kindler was elevated to CEO of Pfizer, Pfizer’s existing head of litigation (Allen Waxman) took over the general counsel job. [read post]
21 Jun 2012, 10:40 am
In re Pfizer Inc. [read post]
17 Jul 2008, 3:15 pm
We're just asking . . .:)By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy. [read post]
25 Jun 2012, 11:44 am
Lee-Jen Wei at 8, 9 (May 5, 2010), in Securities Litig. [read post]
19 Nov 2012, 12:29 am
The opt-out litigation raises much bigger problems for Pfizer and the other defendants. [read post]
1 Mar 2009, 9:00 pm
In a nutshell, plaintiffs pleaded that Pfizer, "working in partnership with the Nigerian government, failed to secure the informed consent" of children (or their guardians) who were enrolled in an allegedly dangerous clinical trial of the drug Trovan. [read post]
19 Sep 2013, 9:53 am
Pfizer, Inc., 712 F.3d 60 (1st Cir. 2013) – all of which also travel under the heading, In re Neurontin Marketing and Sales Practices Litigation. [read post]
25 Jan 2010, 5:00 am
Pfizer, Inc., 2010 WL 163583, slip op. [read post]
1 Mar 2017, 3:08 pm
In Re Lipitor Marketing, Sales Practices and Products Liability Litigation, 2016 WL 7338594 (D.S.C. [read post]
31 Oct 2022, 5:00 am
This “patent linkage” issue can trigger patent litigation. [read post]
23 Feb 2009, 5:04 am
The plaintiffs claim that Pfizer, working in partnership with the Nigerian government, failed to secure the informed consent of either the children or their guardians and specifically failed to disclose or explain the experimental nature of the study or the serious risks involved. [read post]
7 Dec 2009, 6:15 am
See In re Pfizer Inc. [read post]
7 Dec 2009, 6:15 am
See In re Pfizer Inc. [read post]
14 Dec 2007, 1:00 am
Bard Inc.'s patent on a type of prosthetic blood vessel graft, company to pay damages of $185 million: (IPLaw360), Depomed secures summary judgment against Ivax in its patent dispute regarding its AcuForm controlled-release drug delivery technology: (IPLaw360),Dell and Motion Computing hit with patent infringement suit by Typhoon Touch: (IPBiz), EBay vows fight over final judgment in patent suit against MercExchange: (IPLaw360), … [read post]
27 Aug 2017, 10:01 pm
See In re Lipitor Antitrust Litig., 46 F. [read post]
27 Aug 2017, 10:01 pm
See In re Lipitor Antitrust Litig., 46 F. [read post]
2 Sep 2009, 11:22 pm
July 25, 2008) (Texas statute); In re Aredia & Zometa Products Liability Litigation, 2008 WL 913087, at *2 (M.D. [read post]
23 Jul 2012, 7:33 am
In In re Pfizer Inc. [read post]
15 Apr 2015, 12:09 pm
” Id. at *37.Finally, with regard to “duplication or proliferation of litigation – the seventh statutory factor” the Panel disagreed with petitioners’ contention that they would be forced to start at “ground zero” if required to re-file in their home states, pointing out that “any plaintiff family who re-files in their home state will have access to the significant discovery that Pfizer has already… [read post]
19 Feb 2009, 12:55 am
However, by opinion dated January 30, 2009, the United States Court of Appeals for the Third Circuit, relying on a recent decision in In re Merck & Co., Securities Derivative, & ‘ERISA’ Litigation, 543 F. 3d 150 (3d Cir. 2008), reversed the District Court. [read post]
